[Activity Report] The 11th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 23, 2024)
date : 11/7/2024
Tags: AMR
The AMR Consortium of the Asia Africa Medical Innovation Consortium, for which AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) serves as the secretariat, discussed innovation needed to address antimicrobial resistance (AMR) during the “Agenda4 Innovation” in the 11th NIKKEI FT Communicable Diseases Conference, organized by Nikkei Inc. and co-organized by THE FINANCIAL TIMES LTD.
During the meeting, AMR Consortium Co-Chair Kazuhiro Tateda (Professor, Department of Microbiology and Infectious Diseases, Toho University School of Medicine) shared his views on potential innovative solutions to combat AMR, including advancements in the field of drug discovery, vaccine development, bacteriophage therapy, diagnostic methods, approaches utilizing bacterial flora, as well as antibody drugs. He also reflected on the achievements of the AMR Consortium’s activities and policy development on AMR. The pressing need for a pull-type incentive system and the establishment of a drug discovery ecosystem that contributes to infection control measures were also mentioned during the discussion, and participants agreed on its importance and urgency.
[Overview]
- Date: Wednesday, October 23, 2024
- Program: Agenda4 Innovation
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
Featured Posts
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
-
2024-11-01
[Registration Open] Designing for Dementia Briefing Session 2024 – Conversations on the Trajectory of Our Activities and Envisioning the Future (December 3, 2024)
-
2024-11-11
[Discussion Points] Women’s Health Project Expert Meeting “The Ideal System for Perinatal Medical Care in Japan in the Era of Declining Birth Rates” (November 11, 2024)
-
2024-11-11
[Registration Open] (Hybrid Format) Obesity Control Promotion Project Public Symposium “Obesity Control as a Social Issue; Toward the Realization of Citizen-Centered Policies” (December 4, 2024)
-
2024-11-14
[Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)